Michiel L. Bots
There can be much written about my story in life. In short, focusing on my career: My focus was on the development of carotid intima-media thickness measurements as an alternative for cardiovascular events in observational studies and trials. It took up to 2020, before the final piece of that puzzle was published in Circulation.
My drive comes from studies aimed at improvement of clinical care for the patients coming either to the hospital or to primary care. Irrespective whether these are diagnostic studies into prediction rules to predict presence of disease, or prognostic studies aimed at prediction of the occurrence of a certain disease, or intervention studies (i.e., trials) into treatment of conditions to sort out the best treatment for the individual patient.
Contact
Email: m.l.bots@umcutrecht.nl
Phone: +31 88 755 9352
Keywords
Cardiovascular, Electronic Health Care Record, Learning Health Care system, Clinical Epidemiology, Carotid intima media thickness, Chronic Kidney disease, Hypertension, Cohort, Trials, Prediction algorithm.
Research topic
Cardiovascular Epidemiology: design of diagnostic, etiological, prognostic and intervention studies using real world data / real world evidence.
Risk factor topics: elevated blood pressure, chronic kidney disease
Disease topics: various.
Type of research
Clinical Epidemiology: Diagnostic, etiological, prognostic and intervention studies involving humans, dealing with cardiovascular risk factors and/or outcome with emphasis using real world data / real world evidence.
Collaborations / partnerships
Management board CVON studies:
- Queen of hearts (PMID: 29327942); Heart-Brain Connection (29017156); RECONNECT (PMID: 31924185)
Management board trials in chronic kideny disease patients:
- CONTRAST (22539829), MASTERPLAN (15772920), HDF Pooling project (26492924 ), CONVINCE (32029487).
Management board cohorts studies:
Management board real world data
- Julius General Practitioners Network
- Utrecht Cardiovascular Cohort (28128643)
- Nationwade Dutch data on cause of hospital admission and cause death for the entire Ducth population (PMID: 31924185)
Member of the Institute on Personalized, Precise, Preventive Health, a theme to be developed within the TUe-WUR-UU/UMCU Strategic Alliance.
Links Public Private Partners:
• CVRM-IMPROVE (DHF PPS with Ortec )
• Astra-Zeneca (lipid lowering)